Central Pharmaceuticals Limited
(As per abridged
version of Prospectus)
|
|
Nature of Business
|
The principal activities of the Company throughout the
year
continued to be manufacturing and marketing of quality
medicine.
|
Major Product
|
The Company is producing and marketing finished
formulation
products for general Peoples, Hospitals, Clinic, Govt.
Organizations,
NGO’s, Corporations & other Non-govt. Organizations.
|
Subscription Open
|
May 26, 2013
|
Subscription Close
|
May 30, 2013
|
Subscription period for
NRB
|
May 26, 2013 to June 08, 2013
|
Authorized Capital
|
Tk. 1,000,000,000
|
Pre- IPO paid-up Capital
|
Tk. 480,000,000
|
IPO size in shares
|
14,000,000
|
IPO size in Tk. at face value
|
Tk. 140,000,000
|
IPO size in Tk. at offer price
|
Tk. 140,000,000
|
Post IPO Paid-up Capital
|
Tk. 620,000,000
|
Face Value per share
|
Tk. 10.00
|
Offer Price per share
|
Tk. 10.00
|
Market
|
500
|
Use of IPO Proceeds
|
The Company will raise paid-up capital through Initial
Public
Offering (IPO) in order to repayment of its debt to
enhance
profitability.
|
NAV per share
|
Tk. 11.28 as on June 30, 2012.
|
EPS
|
Tk. 1.21 for the year ended on June 30, 2012.
|
Issue Manager
|
Janata Capital and Investment Limited
|
Auditors
|
KAZI ZAHIR KHAN & CO.
|
Website
|
Comments[ 0 ]
একটি মন্তব্য পোস্ট করুন